Outpatient RSV lower respiratory infections among high-risk infants and other pediatric populations

Pediatric Pulmonology

Volumn 45, Issue 6, 2010, Pages 578-584

  Paramore, L Clark ^a   Mahadevia, Parthiv J ^b   Piedra, Pedro A ^c  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b MEDIMMUNE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Burden of illness; Epidemiology; Resource use

Indexed keywords

ARTICLE; BRONCHIOLITIS; CHRONIC LUNG DISEASE; COHORT ANALYSIS; HIGH RISK INFANT; HUMAN; LOWER RESPIRATORY TRACT INFECTION; NEWBORN; OUTPATIENT DEPARTMENT; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RETROSPECTIVE STUDY;

CHILD, PRESCHOOL; COHORT STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; OUTPATIENTS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RISK;

EID: 77953311890     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21224     Document Type: Article

References (18)

1. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-1928.
2. Hall CB, McCarthy CA. Respiratory syncytial virus. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious disease, 5th edition. New York: Churchill Livingstone; 2000. pp. 1872-1881.
3. Paramore LC, Ciuryla V, Ciesla G, Liu L. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics 2004;22:275-284.
4. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999;282:1440-1446.
5. Iwane MK, Edwards KM, Szilagyi PG, Walker FJ, Griffin MR, Weinberg GA, Coulen C, Poehling KA, Shone LP, Balter S, Hall CB, Erdman DD, Wooten K, Schwartz B for the New Vaccine Surveillance Network. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004;113:1758-1764.
6. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003;143:S127-S132.
7. Ogra PL. Respiratory syncytial virus: the virus, the disease and the immune response. Paediatr Respir Rev 2004;5:S119-S126.
8. Bourgeois FT, Valim C, Wei JC, McAdam AJ, Mandl KD. Influenza and other respiratory virus-related emergency department visits among young children. Pediatrics 2006;118:e1-e8.
9. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, Grijalva CG, Zhu Y, Szilagyi P. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 360:588-598.
10. Carroll KN, Gebretsadik T, Griffin MR, Wu P, Dupont WD, Mitchel EF, Enriquez R, Hartert TV. Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan. Pediatrics 2008;122:58-64.
11. Carver K, Cheek JE, Holman RC, Curns AT, Bresee JS, Lingappa JR. Bronchiolitis-associated outpatient visits and hospitalizations among American Indian and Alask Native Children - United States, 1990-2000. MMWR 2003;52:707-710.
12. O'Brien MA, Uyeki TM, Shay DK, Thompson WW, Kleinman K, McAdam A, Yu X, Platt R, Lieu TA. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 2004;113:585-593.
13. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986;140:543-546. (Pubitemid 16120909)
14. Census Bureau. Population Estimates, US, Monthly national population estimates [updated 2008 May 28; cited 2008 September 9]. Available from: http://www.census.gov/popest/national/asrh/2007-nat-detail.html.
15. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr 2003;143:S118-S126.
16. Holman RC, Curns AT, Cheek JE, Bresee JS, Singleton RJ, Carver K, Anderson LI. Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics 2004;114: e437-e444.
17. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics 1998;102:531-537.
18. Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000;283:499-505.